More than four years after the Supreme Court decision in Dobbs v. Jackson, clinical and public health data are beginning to show how changes in abortion law have translated into measurable outcomes. The author, a maternal‑fetal medicine physician, reflects on which widely anticipated effects have materialized, which have not, and what those findings mean for advocates who frame arguments around health outcomes or rights.
Published analyses have identified an increase in infant mortality in states that adopted heavy restrictions on abortion after Dobbs. One study cited reports a relative increase of roughly 5.6% in infant deaths in those states. Two mechanisms are likely contributors. First, explicit bans in some states on terminating pregnancies affected by congenital or genetic anomalies — including conditions inconsistent with survival — have led to more live births of infants with lethal or severe anomalies and, consequently, to more early deaths. Second, people with high‑risk pregnancies who would previously have had abortion as an option have been compelled to continue pregnancies, increasing the number of adverse neonatal outcomes.
A clear national increase in maternal mortality attributable to post‑Dobbs restrictions has not been definitively identified in the available literature. Analyses to date have important caveats. Bans on abortion coincided with the waning phase of the COVID‑19 pandemic, which itself elevated mortality and complicates efforts to disentangle overlapping effects. Aggregate national stability can also obscure state‑level deterioration or disproportionate harm among minoritized groups. Researchers have noted that mortality rates are worse in states that already had abortion bans prior to Dobbs, and that those differences have on average been stable after the decision.
Importantly, even with limited signal in aggregate mortality statistics, individual patients have been documented to have died as a direct result of abortion bans. For affected patients and families, those discrete tragedies are irrevocable and cannot be reduced to population‑level metrics. The author emphasizes that the United States already has maternal and pregnancy‑associated mortality rates worse than peer high‑income countries, so a lack of improvement is itself a public health failure rather than a neutral outcome.
Contrary to expectations that legal restrictions would lead to large declines in abortion frequency, some data indicate that abortions may be stable or even increasing at the national level. Laws are only one of multiple drivers shaping abortion incidence; economic conditions, contraceptive access, societal changes, and clinical availability all influence rates. The oft‑repeated adage that laws do not fully stop abortions appears borne out in current trends.
A major factor preserving access has been the mobilization of advocates, clinicians, and activists who expanded alternative pathways to care, including telehealth and medication abortion. The availability and use of mifepristone have played a central role in maintaining access, although the drug remains subject to legal challenges that could change the landscape.
The author cautions that national averages can mask persistent barriers faced by people living in restrictive states and that preserved access often depends on services that remain legally vulnerable.
Early predictions that large numbers of obstetrician–gynecologists would relocate from restrictive to permissive states have not been realized at a national scale. Recent estimates found net changes near zero or only a modest 1%–2% movement of OB‑GYNs away from restrictive jurisdictions. Individual clinicians have relocated in response to legal change, but the large‑scale exodus that many expected has not occurred according to these analyses.
The author urges careful attention to study methodologies, limitations, and potential for false negatives. Confounding factors such as the pandemic, preexisting state differences, and the delayed manifestation of some workforce or health effects mean that current results could change with more time and data. National aggregates can obscure subpopulation harms and geographic disparities.
Beyond empirical claims, the essay argues for the primacy of ethical grounding in advocacy. Consequentialist arguments focus on downstream health outcomes — metrics clinicians routinely use to choose treatments — but outcomes can be unpredictable or delayed. A strictly outcome‑based approach risks turning debates into disputes over evolving statistics.
By contrast, a deontological framing emphasizes autonomy and freedom: that bans on abortion are moral wrongs because they violate individual liberty and bodily autonomy regardless of measurable public‑health effects. The author warns that relying solely on consequentialist evidence leaves advocates vulnerable to shifting data and to opponents who likewise invoke contested outcome claims.
Current evidence shows some of the worst early predictions after Dobbs have not uniformly materialized, but other harms — notably increased infant mortality in restrictive states and documented individual maternal deaths — have occurred. The author suggests that some consequences may be delayed rather than absent and that legal threats to medication abortion, such as to mifepristone, could alter access quickly.
For advocates, the recommendation is to maintain a rights‑based argument grounded in autonomy and freedom while continuing to monitor and interpret evolving data carefully. Framing opposition to bans on the basis that they are a violation of personal liberty avoids overreliance on epidemiologic trends that may shift, and preserves moral clarity even if future empirical studies yield complex or counterintuitive findings.
The author, David N. Hackney, underscores the professional habit of humility in the face of complex clinical systems and cautions that both data and values matter. While ongoing research will refine our understanding of post‑Dobbs consequences, the essay argues that defending autonomy should remain a central tenet of advocacy regardless of interim statistical findings.